Research groups
Joe Ward
Post-Doctoral Researcher in Cancer Genetics & Evolution
Biography
Qualifications:
- BSc Biomedical Sciences (University of Birmingham)
- PhD (Institute of Genetics & Cancer, University of Edinburgh)
Current Research:
My current work within the Tomlinson Group focuses on defining the epigenetic landscape of colorectal cancer.
Key publications
Analysis of IDH1 and IDH2 mutations as causes of the hypermethylator phenotype in colorectal cancer.
Journal article
Ward JC. et al, (2025), J Pathol, 267, 40 - 55
Replication-associated mechanisms contribute to an increased CpG > TpG mutation burden in mismatch repair-deficient cancers.
Journal article
Ward JC. et al, (2025), Genome Med, 17
Recent publications
Germline haploinsufficiency of MUTYH causes mutational signature SBS18 in multiple tumour types and specifically raises colorectal cancer risk.
Journal article
Sherwood K. et al, (2026), NPJ Precis Oncol
DNA methylation signatures of mismatch repair-deficient colorectal cancer
Preprint
Ward R. et al, (2026)
Analysis of IDH1 and IDH2 mutations as causes of the hypermethylator phenotype in colorectal cancer.
Journal article
Ward JC. et al, (2025), J Pathol, 267, 40 - 55
Replication-associated mechanisms contribute to an increased CpG > TpG mutation burden in mismatch repair-deficient cancers.
Journal article
Ward JC. et al, (2025), Genome Med, 17
Germline de novo mutations in families with Mendelian cancer syndromes caused by defects in DNA repair.
Journal article
Sherwood K. et al, (2023), Nat Commun, 14